ArtiQ
ArtiQ provides AI-powered software for diagnosing and managing lung diseases through analysis of pulmonary function tests.
ArtiQ empowers medical professionals with artificial intelligence to accurately and timely diagnose, treat and follow-up patients with lung diseases. The company provides AI-first software to optimize clinical trials, enhance diagnostic processes, and improve patient outcomes. ArtiQ is now part of Clario.
Key People
Bart Swaelens - Co-Founder & Board Member- Wim Janssens - Co-Founder & Board Member
- Marc Decramer - Co-Founder & Board Member